Kuroda Hajime, Imai Yasuo, Yamagishi Hidetsugu, Ueda Yoshihiko, Kuroso Kazuko, Oishi Yoko, Ohashi Hitoshi, Yamashita Akinori, Yashiro Yoshiko, Fukushima Hisaki
Department of Pathology, International University of Health and Welfare Hospital, Tochigi, Japan; Department of Diagnostic Pathology, Dokkyo Medical University, Tochigi, Japan.
Department of Diagnostic Pathology, Dokkyo Medical University, Tochigi, Japan.
Ann Diagn Pathol. 2016 Feb;20:36-9. doi: 10.1016/j.anndiagpath.2015.10.007. Epub 2015 Oct 31.
Early studies characterizing the keratin (K) profile of various epithelial tissues indicated that breast carcinoma is K7 positive and K20 negative, but not all breast carcinomas show this profile. Triple-negative carcinoma (TNC) has been characterized by negativity for estrogen receptor (ER), progesterone receptor (PgR), and Her2/neu protein. TNC is more likely to metastasize to the viscera and present as a metastatic poorly different carcinoma. In our study, on the basis of immunohistochemical staining of ER, PgR, and Her2/neu, 75 of the 290 patients with invasive breast carcinoma were judged to have TNC. K20 expression was detected in 6 of 75 patients with TNC, and non-TNC was negative in all 215 cases (P = .0003). K7 expression was also detected in 72 of 75 TNC cases. However, non-TNC was negative in 26 of 215 cases, which was significant (P = .0457). An aberrant profile of K was observed in the TNC group, indicating that caution is needed in determining the site of primary tumors using immunohistochemical algorithms. It should be kept in mind that patients with TNC show highly variable K profiles in practical diagnosis.
早期对各种上皮组织角蛋白(K)谱特征的研究表明,乳腺癌呈K7阳性、K20阴性,但并非所有乳腺癌都呈现这种特征。三阴性乳腺癌(TNC)的特征是雌激素受体(ER)、孕激素受体(PgR)和Her2/neu蛋白均为阴性。TNC更易转移至内脏,表现为转移性低分化癌。在我们的研究中,根据ER、PgR和Her2/neu的免疫组化染色结果,290例浸润性乳腺癌患者中有75例被判定为TNC。75例TNC患者中有6例检测到K20表达,而215例非TNC患者均为阴性(P = 0.0003)。75例TNC病例中有72例也检测到K7表达。然而非TNC患者中有26例为阴性,差异有统计学意义(P = 0.0457)。在TNC组中观察到K谱异常,这表明在使用免疫组化算法确定原发肿瘤部位时需谨慎。应牢记,TNC患者在实际诊断中K谱表现高度可变。